[go: up one dir, main page]

ES534259A0 - Procedimiento para preparar nuevos derivados de imidazo (1,5-a) pirimidina - Google Patents

Procedimiento para preparar nuevos derivados de imidazo (1,5-a) pirimidina

Info

Publication number
ES534259A0
ES534259A0 ES534259A ES534259A ES534259A0 ES 534259 A0 ES534259 A0 ES 534259A0 ES 534259 A ES534259 A ES 534259A ES 534259 A ES534259 A ES 534259A ES 534259 A0 ES534259 A0 ES 534259A0
Authority
ES
Spain
Prior art keywords
pirimidina
procedure
preparing new
new imidazo
imidazo derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES534259A
Other languages
English (en)
Other versions
ES8604589A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of ES534259A0 publication Critical patent/ES534259A0/es
Publication of ES8604589A1 publication Critical patent/ES8604589A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES534259A 1983-07-12 1984-07-12 Procedimiento para preparar nuevos derivados de imidazo (1,5-a) pirimidina Expired ES8604589A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58126697A JPS6019789A (ja) 1983-07-12 1983-07-12 イミダゾ〔1,5−a〕ピリミジン誘導体

Publications (2)

Publication Number Publication Date
ES534259A0 true ES534259A0 (es) 1986-02-01
ES8604589A1 ES8604589A1 (es) 1986-02-01

Family

ID=14941605

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534259A Expired ES8604589A1 (es) 1983-07-12 1984-07-12 Procedimiento para preparar nuevos derivados de imidazo (1,5-a) pirimidina

Country Status (9)

Country Link
US (1) US4649198A (es)
EP (1) EP0134928B1 (es)
JP (1) JPS6019789A (es)
KR (1) KR910005850B1 (es)
AU (1) AU563849B2 (es)
CA (1) CA1238045A (es)
DE (1) DE3469177D1 (es)
DK (1) DK339584A (es)
ES (1) ES8604589A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143191A (ja) * 1984-08-07 1986-03-01 Kyorin Pharmaceut Co Ltd イミダゾ〔1,5−a〕ピリミジン誘導体
HU215433B (hu) * 1986-04-29 2000-05-28 Pfizer Inc. Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására
US5395935A (en) * 1992-05-08 1995-03-07 Pfizer Inc. Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
US7166595B2 (en) * 2002-05-09 2007-01-23 Cytokinetics, Inc. Compounds, methods and compositions
EP1509507A4 (en) * 2002-05-23 2006-09-13 Merck & Co Inc INHIBITORS OF MITOTIC KINESINE
CA2484761C (en) * 2002-05-24 2010-11-09 Angiotech International Ag Compositions and methods for coating medical implants
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
CN100474907C (zh) * 2003-06-18 2009-04-01 汤姆森特许公司 在电影胶片上记录数据的装置
EP1697331A4 (en) 2003-12-19 2010-08-04 Merck Sharp & Dohme INHIBITORS OF MITOTIC KINESINE
WO2022002243A1 (zh) * 2020-07-02 2022-01-06 江苏恒瑞医药股份有限公司 咪唑并嘧啶类衍生物、其制备方法及其在医药上的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2160020A1 (de) * 1971-12-03 1973-06-07 Bayer Ag Perchlor-imidazo-pyrimidin, verfahren zu seiner herstellung, sowie seine verwendung als fungizid
US3923808A (en) * 1972-12-08 1975-12-02 Janssen Pharmaceutica Nv Bicyclic imidazoles and pyrimidines
US4178449A (en) * 1978-04-17 1979-12-11 American Cyanamid Company Pyrazolo[1,5-a]pyrimidines and imidazo-[1,5-a]pyrimidines
US4236005A (en) * 1979-07-02 1980-11-25 American Cyanamid Company Imidazo[1,5-a]pyrimidines
US4408047A (en) * 1980-03-28 1983-10-04 Merck & Co., Inc. Imidazodiazines

Also Published As

Publication number Publication date
KR910005850B1 (ko) 1991-08-05
DK339584D0 (da) 1984-07-11
US4649198A (en) 1987-03-10
KR850001213A (ko) 1985-03-16
AU2937184A (en) 1985-01-17
JPS6019789A (ja) 1985-01-31
DE3469177D1 (en) 1988-03-10
EP0134928A1 (en) 1985-03-27
CA1238045A (en) 1988-06-14
EP0134928B1 (en) 1988-02-03
DK339584A (da) 1985-01-13
ES8604589A1 (es) 1986-02-01
JPH0450315B2 (es) 1992-08-13
AU563849B2 (en) 1987-07-23

Similar Documents

Publication Publication Date Title
ES535978A0 (es) Procedimiento para preparar derivados de tiazol
MX7199E (es) Procedimiento para preparar derivados de 3-cetodelta-4,9,19-nor-esteroides
ES557118A0 (es) Procedimiento para preparar (1,2,4) triazolo (1,5-c) quinazolinas
ES531285A0 (es) Procedimiento de preparacion de derivados de 1,3-dihidro-6-metil-7-hidroxi-furo-(3,4-c)-piridina
ES536138A0 (es) Procedimiento para preparar derivados azolicos
ES537665A0 (es) Procedimiento para preparar derivados de 1, 3-dihidro-6-vinil-7-hidroxifuro-(3, 4-c)-piridina
ES529371A0 (es) Procedimiento para la preparacion de derivados de imidazo (1, 2-c) pirazolo (3, 4-e) pirimidina
ES539255A0 (es) Procedimiento para preparar derivados de isoquinoleina
DE3376324D1 (de) Imidazo(1,5-a)pyridine derivatives
MX157033A (es) Procedimiento para preparar derivados de pirrolo quinoleina
ES534259A0 (es) Procedimiento para preparar nuevos derivados de imidazo (1,5-a) pirimidina
AR231447A1 (es) Procedimiento para preparar derivados de 4,5-dihidro-imidazo 1,2-a-quinazolin-2 1h-ona
ES525186A0 (es) Procedimiento para preparar nuevas imidazo-(1,2-a)-pirimidinas
AR229600A1 (es) Procedimiento para preparar derivados de 1,2,3-triazolo(4,5-b)(1,5)benzodiazepina
MX7403E (es) Procedimiento para preparar derivados de benzoil-ureas
ES534377A0 (es) Procedimiento para preparar derivados de antraciclina
ES543518A0 (es) Procedimiento para la obtencion de nuevas imidazo(1,5-a)pi- ridinas
ES525686A0 (es) Procedimiento para la obtencion de imidazo (1,5-a)piridinas
ES552547A0 (es) Procedimiento para preparar derivados de pirazol-(1,5-a)piridina
ES545929A0 (es) Un procedimiento para preparar derivados de imidazo(1,2-a) quinoleinas
ES537010A0 (es) Procedimiento para preparar derivados de acidos 1-oxido-1, 2-ditiolano-carboxilicos
ES544772A0 (es) Procedimiento para preparar derivados de pirazol(1,5-a) pi- ridina
ES537959A0 (es) Procedimiento para preparar derivados de imidazol.
ES530626A0 (es) Procedimiento para preparar derivados de ciano-2-imidazopiridina
ES540594A0 (es) Procedimiento de preparar 7,8 dihidroimidazo (1,5-a) piraci-na-8-onas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401